CYP21-catalyzed production of the long-term urinary metandienone metabolite 17i-hydroxymethyl-17i-methyl-18-norandrosta-1, 4, 13-trien-3-one a contribution toae: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

    11 August 2022

    • curprev 22:0822:08, 11 August 2022‎ 187.21.138.9 talk‎ 594 bytes +594‎ Created page with "== Target Article == CYP21-catalyzed production of the long-term urinary metandienone metabolite 17i-hydroxymethyl-17i-methyl-18-norandrosta-1, 4, 13-trien-3-one a contribution toae; A Zallner, MK Parr, CA Dragan, S Drasae; 2010; doi_citing_unknown == Retraction == Bilateral ovarian steroid cell tumor in congenital adrenal hyperplasia due to classic 11ß-hydroxylase deficiency ; Firdevs Bas Nucin Saka Feyza Darendeliler Siki Tuzlah Ridvan Ilhan Ruveyde Bundak Huly..."
Retrieved from "https://wikicitingretracted.org/index.php?title=CYP21-catalyzed_production_of_the_long-term_urinary_metandienone_metabolite_17i-hydroxymethyl-17i-methyl-18-norandrosta-1,_4,_13-trien-3-one_a_contribution_toae"